igf-1 lr3 clinical trial IGF-1 LR3 1MG Research Peptide

This lack of standardization, spanning from the sourcing of medicinal materials to dosing protocols, not only complicates inter-study comparisons but also undermines the interpretability and clinical applicability of research outcomes

Nature 563 , 714718 (2018)

Cytoprotective activity against MPP + -induced cytotoxicity SH-SY5Y cells grown in 96-well plates at a density of 4 10 4 cells/well for 24 h were pretreated with blank LPs, free ASX, ASX-LPs, or Lf-ASX-LPs (equivalent to 18 M ASX) for 6 h, incubated with 2 mM MPP + for 24 h, and cell viability was measured using the MTT assay

Acta Neuropathol 125:231243

They are segregated based on texture and ingredients mostly